patritumab
Daiichi Sankyo,Amgen
['breast', 'her3-dxd', 'bcsm', 'tnbc']
her3-dxd elicits responses and safety in heavily pretreated er+ breast cancer and tnbc #asco23 #asco2023 #bcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.